Form 4 for ERAS Erasca, Inc.
Accepted 2023-02-03 00:00:00 ET · period of report 2023-02-01 · accession 0001209191-23-006480 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-03 | 2023-02-01 | ERAS | Wei Lin | Chief Medical Off | J - Other | $4.10 | +1,750 | 315.8K | +0.6% | +$7,175 |
| D | 2023-02-03 | 2023-02-01 | ERAS | Wei Lin | Chief Medical Off | A - Grant | $0.00 | +560.0K | 560.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | J | A | 2 | $3.89 | 315,812 | D | — | — | (F1) Includes 1,748 shares acquired under the Erasca, Inc. Employee Stock Purchase Plan (the ESPP) on June 15, 2022 and 2 shares acquired under the ESPP on December 15, 2022. |
| 2 | Common | Common Stock | 2023-02-01 | J | A | 1,748 | $4.10 | 315,812 | D | — | — | (F1) Includes 1,748 shares acquired under the Erasca, Inc. Employee Stock Purchase Plan (the ESPP) on June 15, 2022 and 2 shares acquired under the ESPP on December 15, 2022. |
| 3 | Derivative | Stock Option (right to buy) | 2023-02-01 | A | A | 560,000 | $0.00 | 560,000 | D | $4.00 · — to 2033-01-31 | 560,000 Common Stock | (F2) 1/48th of the shares subject to the option vest monthly following February 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such vesting date. |